HVO Hvivo Plc

TIDMVENN

RNS Number : 7406B

Venn Life Sciences Holdings PLC

20 June 2016

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Shareholder notification

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device clients, has been informed today that Mr David Newton no longer holds a notifiable shareholding in the Company.

Enquiries:

 
 Venn Life Sciences Holdings Plc                                  www.vennlifesciences.com 
 Tony Richardson, Chief Executive Officer                             Tel: +353 154 99 341 
 Jonathan Hartshorn, Chief Financial Officer                          Tel: +353 153 93 269 
 Aoife O Farrell, Marketing Manager                                   Tel: +353 153 93 269 
 
 Davy (Nominated Adviser, ESM Adviser                                 Tel: +353 1 679 6363 
  and Joint Broker) 
 Fergal Meegan / Matthew DeVere White 
  (Corporate Finance) 
 Paul Burke (Corporate Broking) 
 
 Hybridan LLP (Joint-Broker) 
 Claire Louise Noyce                                                    Tel: 020 3764 2341 
 
 Walbrook PR Ltd                                 Tel: 020 7933 8787 or venn@walbrookpr.com 
 Paul McManus                                                           Mob: 07980 541 893 
 Lianne Cawthorne                                                       Mob: 07584 391 303 
 
 

About Venn Life Sciences Limited: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn Life Sciences specialises in rapid deployment and management of multisite projects, across all phases. Venn Life Sciences also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

For more information about the Company, please visit: www.vennlifesciences.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHAKKDDPBKDFAB

(END) Dow Jones Newswires

June 20, 2016 11:24 ET (15:24 GMT)

Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024